Amgen Q3 Results - Q3 Top Pharma Company Earnings Reports

View Amgen's Q3 Earnings Report

Highlights:

  • Amgen reported adjusted earnings per share (EPS) of $1.49 for the third quarter of 2009, an increase of 21 percent compared to $1.23 for the third quarter of 2008.
  • Adjusted net income increased 16 percent to $1,518 million in the third quarter of 2009 compared to $1,308 million in the third quarter of 2008.
  • Total revenue decreased 2 percent during the third quarter of 2009 to $3,812 million versus $3,875 million in the third quarter of 2008.

Check out Amgen's current earnings estimates from CNN Money

Amgen's Website: http://www.amgen.com/

Amgen Q3 Results - Q3 Top Pharma Company Earnings Reports
Read more on

Suggested Articles

Novavax has inked a $60 million contract with the U.S. Department of Defense to help fund U.S.-based manufacturing of its COVID-19 vaccine candidate.

Since the Warp Speed selections went public, experts have been wondering why some drugmakers were left off.

Vaccine maker Inovio has accused a longtime manufacturing partner of hampering its efforts to produce 1 million doses of a potential COVID-19 vaccine.